|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online September 20, 2006
doi: 10.1242/10.1242/jcs.03098
Cell Science at a Glance |

Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, University of Manchester, Michael Smith Building, Oxford Road, Manchester, M13 9PT, UK
Author for correspondence (e-mail: martin.humphries{at}manchester.ac.uk)
| Introduction |
|---|
|
|
|---|
and a ß subunit. Both subunits are type I transmembrane proteins, containing large extracellular domains and mostly short cytoplasmic domains (Springer and Wang, 2004
subunit and 8 ß subunit genes, and to date 24 different
-ß combinations have been identified at the protein level. Although some subunits appear only in a single heterodimer, 12 integrins contain the ß1 subunit, and five contain
V.
Integrin function has been determined through a combination of cell biological and genetic analyses. On the cytoplasmic face of the plasma membrane, integrin occupancy coordinates the assembly of cytoskeletal polymers and signalling complexes; on the extracellular face, integrins engage either extracellular matrix macromolecules or counter-receptors on adjacent cell surfaces. These bidirectional linkages impose spatial restrictions on signalling and extracellular matrix assembly, and thereby integrate cells with their microenvironment. In turn, membrane-proximal interactions initiate more distal functions such as tissue patterning (extracellularly) and cell fate determination (intracellularly). Genetic analyses of engineered or natural mutations have confirmed key roles for integrins in tissue integrity, cell trafficking, and differentiation (Bouvard et al., 2001
; Bokel and Brown, 2002
).
| Aims of this article |
|---|
|
|
|---|
|
| Integrin-ligand partners |
|---|
|
|
|---|
RGD-binding integrins
All five
V integrins, two ß1 integrins (
5,
8) and
IIbß3 share the ability to recognise ligands containing an RGD tripeptide active site. Crystal structures of
Vß3 and
IIbß3 complexed with RGD ligands have revealed an identical atomic basis for this interaction (Xiong et al., 2002
; Xiao et al., 2004
). RGD binds at an interface between the
and ß subunits, the R residue fitting into a cleft in a ß-propeller module in the
subunit, and the D coordinating a cation bound in a von Willebrand factor A-domain in the ß subunit. The RGD-binding integrins are among the most promiscuous in the family, with ß3 integrins in particular binding to a large number of extracellular matrix and soluble vascular ligands. Although many ligands are shared by this subset of integrins, the rank order of ligand affinity varies, presumably reflecting the preciseness of the fit of the ligand RGD conformation with the specific
-ß active site pockets.
LDV-binding integrins
4ß1,
4ß7,
9ß1, the four members of the ß2 subfamily and
Eß7 recognise related sequences in their ligands.
4ß1,
4ß7 and
9ß1 bind to an acidic motif, termed `LDV', that is functionally related to RGD. Fibronectin contains the prototype LDV ligand in its type III connecting segment region, but other ligands (such as VCAM-1 and MAdCAM-1) employ related sequences. Although definitive structural information is lacking, it is highly likely that LDV peptides bind similarly to RGD at the junction between the
and ß subunits. Osteopontin also interacts with
4ß1,
4ß7 and
9ß1, but this apparently involves a different peptide motif, SVVYGLR, and the location of the ligand-binding site has not been identified.
The ß2 family employ a different mode of ligand binding, the major interaction taking place through an inserted A-domain in the
subunit (see Shimaoka et al., 2003
for the structure of a complex between the
L A-domain and ICAM-1). However, despite this fundamental mechanistic difference, the characterised sites within ligands that bind ß2 integrins are structurally similar to the LDV motif. The major difference is that ß1/ß7 ligands employ an aspartate residue for cation coordination whereas ß2 integrins use glutamate. Collectively, therefore, the LDV motif can be described by the consensus sequence L/I-D/E-V/S/T-P/S.
A-domain ß1 integrins
Four
subunits containing an
A-domain (
1,
2,
10 and
11) combine with ß1 and form a distinct laminin/collagen-binding subfamily. Few other validated ligands have been identified for these integrins. A crystal structure of a complex between the
2 A-domain and a triple-helical collagenous peptide has revealed the structural basis of the interaction, a critical glutamate within a collagenous GFOGER motif providing the key cation-coordinating residue (Emsley et al., 2000
). Currently, the mechanism of laminin binding is unknown.
Non-
A-domain-containing laminin-binding integrins
Three ß1 integrins (
3,
6 and
7), plus
6ß4, are highly selective laminin receptors. Analysis of laminin fragments indicates that these receptors and the A-domain-containing ß1 integrins bind to different regions of the ligands. In neither case has the active site been narrowed down to a particular sequence or residue.
| Additional integrin-ligand interactions |
|---|
|
|
|---|
4ß1,
5ß1,
6ß1,
9ß1,
Vß3 and
Vß6; COMP interacts with
5ß1 and
vß3; connective tissue growth factor interacts with
Vß3 and
IIbß3; Cyr61 interacts with
6ß1,
IIbß3,
Vß3 and
Dß2; E-cadherin interacts with
2ß1; ESM-1 interacts with
Lß2; fibrillin interacts with
5ß1; fibrinogen interacts with
Dß2; fibronectin interacts with
Dß2; ICAM-4 interacts with
4ß1,
Lß2,
Mß2,
Xß2,
Vß3 and
IIbß3; LAP-TGFß interacts with
8ß1 and
Vß5; MMP-2 interacts with
Vß3; nephronectin interacts with
8ß1; L1 interacts with
5ß1,
Vß1,
Vß3 and
IIbß3; plasminogen interacts with
Dß2; POEM interacts with
8ß1; tenascin interacts with
2ß1; thrombospondin interacts with
5ß1 and
6ß1; VEGF-C and VEGF-D interact with
9ß1; and vitronectin interacts with
Dß2. Note also that both
Mß2 and
Xß2 interact with heparin and negative charges in denatured proteins. | Lessons from evolution |
|---|
|
|
|---|
) and five
subunits. ß
has no known
subunit partner, but ßPS combines with subunits that cluster with the laminin-binding and RGD-binding integrins. The remaining
chains form a Drosophila-specific clade. A similar complement of integrins is found in Caenorhabditis elegans, which suggests that the earliest metazoans possessed two primordial integrins: one laminin-specific and one RGD-ligand-specific.
The genome of the early chordate Ciona intestinalis encodes eleven
and five ß chain genes (Ewan et al., 2005
). Two Ciona
chains cluster with laminin-binding subunits and a third clusters with RGD-binding subunits. Surprisingly, eight
chains contain an
A-domain that is related to but, distinct from, the vertebrate
A-domains. Since these subunits are expressed predominantly in blood cells, they may play a role in innate immunity. It therefore seems that collagen-binding capabilities appeared in the chordate lineage after the divergence of ascidians. Of the five Ciona ß chains, one clusters with ß1, one clusters with ß4, and three form an ascidian-specific clade.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Arnaout, M. A., Mahalingam, B. and Xiong, J. P. (2005). Integrin structure, allostery, and bidirectional signaling. Annu. Rev. Cell Dev. Biol. 21, 381-410.[CrossRef][Medline]
Bokel, C. and Brown, N. H. (2002). Integrins in development: moving on, responding to, and sticking to the extracellular matrix. Dev. Cell. 3, 311-321.[CrossRef][Medline]
Bouvard, D., Brakebusch, C., Gustafsson, E., Aszodi, A., Bengtsson, T., Berna, A. and Fassler, R. (2001). Functional consequences of integrin gene mutations in mice. Circ. Res. 89, 211-223.
Emsley, J., Knight, C. G., Farndale, R. W., Barnes, M. J. and Liddington, R. C. (2000). Structural basis of collagen recognition by integrin alpha2beta1. Cell 101, 47-56.[CrossRef][Medline]
Ewan, R., Huxley-Jones, J., Mould, A. P., Humphries, M. J., Robertson, D. L. and Boot-Handford, R. P. (2005). The integrins of the urochordate Ciona intestinalis provide novel insights into the molecular evolution of the vertebrate integrin family. BMC Evol. Biol. 5, 31.[CrossRef][Medline]
Humphries, M. J. (1990). The molecular basis and specificity of integrin-ligand interactions. J. Cell Sci. 97, 585-592.
Humphries, M. J. (2000). Integrin structure. Biochem. Soc. Trans. 28, 311-339.[Medline]
Hynes, R. O. (2002). Integrins: bidirectional, allosteric signaling machines. Cell 110, 673-687.[CrossRef][Medline]
Hynes, R. O. and Zhao, Q. (2000). The evolution of cell adhesion. J. Cell Biol. 150, F89-F96.
Plow, E. F., Haas, T. A., Zhang, L., Loftus, J. and Smith, J. W. (2000). Ligand binding to integrins. J. Biol. Chem. 275, 21785-21788.
Shimaoka, M., Xiao, T., Liu, J. H., Yang, Y., Dong, Y., Jun, C. D., McCormack, A., Zhang, R., Joachimiak, A., Takagi, J. et al. (2003). Structures of the alpha L I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation. Cell 112, 99-111.[CrossRef][Medline]
Springer, T. A. and Wang, J. H. (2004). The three-dimensional structure of integrins and their ligands, and conformational regulation of cell adhesion. Adv Protein Chem. 68, 29-63.[Medline]
van der Flier, A. and Sonnenberg, A. (2001). Function and interactions of integrins. Cell Tissue Res. 305, 285-298.[CrossRef][Medline]
Xiao, T., Takagi, J., Coller, B. S., Wang, J. H. and Springer, T. A. (2004). Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 432, 59-67.[CrossRef][Medline]
Xiong, J. P., Stehle, T., Zhang, R., Joachimiak, A., Frech, M., Goodman, S. L. and Arnaout, M. A. (2002). Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. Science 296, 151-155.
This article has been cited by other articles:
![]() |
M. W. Johansson, E. A. B. Kelly, W. W. Busse, N. N. Jarjour, and D. F. Mosher Up-Regulation and Activation of Eosinophil Integrins in Blood and Airway after Segmental Lung Antigen Challenge J. Immunol., June 1, 2008; 180(11): 7622 - 7635. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Meads, L. A. Hazlehurst, and W. S. Dalton The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance Clin. Cancer Res., May 1, 2008; 14(9): 2519 - 2526. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Vallacchi, M. Daniotti, F. Ratti, D. Di Stasi, P. Deho, A. De Filippo, G. Tragni, A. Balsari, A. Carbone, L. Rivoltini, et al. CCN3/Nephroblastoma Overexpressed Matricellular Protein Regulates Integrin Expression, Adhesion, and Dissemination in Melanoma Cancer Res., February 1, 2008; 68(3): 715 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Bharadwaj, K. Rector, and M. A. Simpson Inducible Hyaluronan Production Reveals Differential Effects on Prostate Tumor Cell Growth and Tumor Angiogenesis J. Biol. Chem., July 13, 2007; 282(28): 20561 - 20572. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||